Healthcare Provider Knowledge of West Nile Virus Diagnostic Testing—United States, 2022 - Takeaways - MDSpire

Healthcare Provider Knowledge of West Nile Virus Diagnostic Testing—United States, 2022

  • By

  • Shelby L Lyons

  • Stacey W Martin

  • Carolyn V Gould

  • J Erin Staples

  • June 27, 2025

  • 0 min

Share

  • 1

    A survey of 1502 U.S. healthcare providers revealed only 26% ordered the correct tests for diagnosing West Nile virus disease.

  • 2

    Most West Nile virus infections are asymptomatic, but 20% develop acute illness, and less than 1% progress to neuroinvasive disease.

  • 3

    Accurate diagnosis of West Nile virus is crucial for patient management, public health surveillance, and prevention measures.

  • 4

    Healthcare providers often selected unnecessary tests, leading to excess costs of over $58,000 for incorrect diagnostic choices.

  • 5

    Internists demonstrated a higher likelihood of selecting appropriate diagnostic tests compared to family practitioners and nurse practitioners.

Original Source(s)

Healthcare Provider Knowledge of West Nile Virus Diagnostic Testing—United States, 2022

  • by Shelby L Lyons, Stacey W Martin, Carolyn V Gould, J Erin Staples

  • June 27, 2025

Related Content

Epstein-Barr Virus Central Nervous System Infections and Mortality Risk in Patients Presenting With Suspected Meningitis: Results From the Botswana National Meningitis Survey and the Harare Meningitis Aetiology Study

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Evaluating the Clinical Impact of Metagenomic Next-Generation Sequencing in CNS Infections: A Diagnostic Pathway and Resource Utilization Modeling Study